Literature DB >> 23184039

Alcohol withdrawal and delirium tremens in the critically ill: a systematic review and commentary.

Don-Kelena Awissi1, Genevieve Lebrun, Douglas B Coursin, Richard R Riker, Yoanna Skrobik.   

Abstract

INTRODUCTION: Alcohol withdrawal is common among intensive care unit (ICU) patients, but no current practice guidelines exist. We reviewed published manuscripts for prevalence, risk factors, screening tools, prophylactic and treatment strategies, and outcomes for alcohol withdrawal syndrome (AWS) and delirium tremens (DT) in the critically ill.
METHODS: The following databases: PubMed, MEDLINE, Embase, Cochrane Database of Systematic Reviews and Central Register of Controlled Trials, CINAHL, Scopus, Web of Knowledge, pain, anxiety and delirium (PAD) Guidelines REFWORKS, International Pharmaceutical Abstracts and references for published papers were searched. Publications with high or moderate Grading of Recommendations Assessment, Development and Evaluation (GRADE) and Oxford levels of evidence were included.
RESULTS: Reported AWS rates range from <1 % in 'all ICU comers' to 60 % in highly selected alcohol-dependent ICU patients. Alcohol dependence and a history of withdrawal are significant risk factors for AWS occurrence. No screening tools for withdrawal have been validated in the ICU. The benefit of alcohol withdrawal prophylaxis is unproven, and proposed regimens appear equivalent. Early and aggressive titration of medication guided by symptoms is the only feature associated with improved treatment outcome.
CONCLUSIONS: Treatment of AWS is associated with higher ICU complication rates and resource utilization. The optimal means of identification, prevention and treatment of AWS in order to establish evidence-based guidelines remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184039     DOI: 10.1007/s00134-012-2758-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  56 in total

1.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

2.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

Authors:  J T Sullivan; K Sykora; J Schneiderman; C A Naranjo; E M Sellers
Journal:  Br J Addict       Date:  1989-11

3.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

4.  Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.

Authors:  Douglas D DeCarolis; Kathryn L Rice; Libin Ho; Mark L Willenbring; Susan Cassaro
Journal:  Pharmacotherapy       Date:  2007-04       Impact factor: 4.705

5.  Incidence, risk factors and consequences of ICU delirium.

Authors:  Sébastien Ouimet; Brian P Kavanagh; Stewart B Gottfried; Yoanna Skrobik
Journal:  Intensive Care Med       Date:  2006-11-11       Impact factor: 17.440

6.  Alcohol withdrawal syndrome: Turning minor injuries into a major problem.

Authors:  Michael R Bard; Claudia E Goettler; Eric A Toschlog; Scott G Sagraves; Paul J Schenarts; Mark A Newell; Mark Fugate; Michael F Rotondo
Journal:  J Trauma       Date:  2006-12

7.  Probable alcohol abuse or dependence: a risk factor for intensive-care readmission in patients undergoing elective vascular and thoracic surgical procedures. Mayo Perioperative Outcomes Group.

Authors:  P M Maxson; K L Schultz; K H Berge; C M Lange; D R Schroeder; T A Rummans
Journal:  Mayo Clin Proc       Date:  1999-05       Impact factor: 7.616

8.  Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial.

Authors:  Timothy D Girard; John P Kress; Barry D Fuchs; Jason W W Thomason; William D Schweickert; Brenda T Pun; Darren B Taichman; Jan G Dunn; Anne S Pohlman; Paul A Kinniry; James C Jackson; Angelo E Canonico; Richard W Light; Ayumi K Shintani; Jennifer L Thompson; Sharon M Gordon; Jesse B Hall; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

9.  Improved outcomes in patients with head and neck cancer using a standardized care protocol for postoperative alcohol withdrawal.

Authors:  Christopher D Lansford; Cathleen H Guerriero; Mary J Kocan; Richard Turley; Michael W Groves; Vinita Bahl; Paul Abrahamse; Carol R Bradford; Douglas B Chepeha; Jeffrey Moyer; Mark E Prince; Gregory T Wolf; Michelle L Aebersold; Theodoros N Teknos
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-08

10.  Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.

Authors:  Christoph Elsing; Wolfgang Stremmel; Uwe Grenda; Thomas Herrmann
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

View more
  20 in total

1.  The Assessment and Management Practices of Acute Alcohol Withdrawal: Results of a Nationwide Survey of Critical Care Pharmacists.

Authors:  Susanne Dyal; Robert MacLaren
Journal:  Hosp Pharm       Date:  2018-04-13

2.  Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients.

Authors:  Elie Azoulay; Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2014-01-24       Impact factor: 17.440

Review 3.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

4.  Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review.

Authors:  Drayton A Hammond; Jordan M Rowe; Adrian Wong; Tessa L Wiley; Kristen C Lee; Sandra L Kane-Gill
Journal:  Hosp Pharm       Date:  2017-07-17

5.  Recalibration of the delirium prediction model for ICU patients (PRE-DELIRIC): a multinational observational study.

Authors:  M van den Boogaard; L Schoonhoven; E Maseda; C Plowright; C Jones; A Luetz; P V Sackey; P G Jorens; L M Aitken; F M P van Haren; R Donders; J G van der Hoeven; P Pickkers
Journal:  Intensive Care Med       Date:  2014-01-18       Impact factor: 17.440

Review 6.  Alcoholism and critical illness: A review.

Authors:  Ashish Jitendra Mehta
Journal:  World J Crit Care Med       Date:  2016-02-04

7.  [Dexmedetomidine in the treatment of acute alcohol withdrawal delirium].

Authors:  G Gerresheim; J Brederlau; U Schwemmer
Journal:  Anaesthesist       Date:  2016-07       Impact factor: 1.041

8.  Alcohol withdrawal is associated with poorer outcome in acute ischemic stroke.

Authors:  Emmanuel O Akano; Fadar Oliver Otite; Seemant Chaturvedi
Journal:  Neurology       Date:  2019-10-25       Impact factor: 9.910

Review 9.  Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research.

Authors:  Andrew J Muzyk; Suzanne Kerns; Scott Brudney; Jane P Gagliardi
Journal:  CNS Drugs       Date:  2013-11       Impact factor: 5.749

Review 10.  Perioperative Management of Alcohol Withdrawal Syndrome.

Authors:  Alexander Lavinius Ungur; Tim Neumann; Friedrich Borchers; Claudia Spies
Journal:  Visc Med       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.